Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced today that the U.S. Food ...

Efficient no-code solution with its own IDE for easier development.

These entrants are competing with far bigger players, including OpenAI, Anthropic, and Microsoft, that make their own ...

A SimpleHelp authentication flaw is being exploited to deploy Djinn Stealer, a cross-platform malware targeting cloud, ...

Nextcloud CEO: Open source moves from 'a nerdy audience' to the geopolitical stage Frank Karlitschek, head of the German software vendor, talked about the company’s decision to help develop the ...